Affordable Access

KDIGO – prise en charge de l’hypertension artérielle en dialyse

Publication Date
  • Kdigo
  • Hypertension Artérielle
  • Dialyse
  • Human Health Sciences :: Urology & Nephrology [D27]
  • Sciences De La Santé Humaine :: Urologie & Néphrologie [D27]
  • Biology


1. A lower target may be chosen in CKD patients with proteinuria but after individualized risk-benefit assessment. The price to pay is a need for a higher number of antiHTA drugs and a risk of more frequent side-effects. 2. Confirmation of a high BP level is necessary through out-of-the clinic BP measurement In CKD, ABPM offers night-time BP information useful for CV and renal risk evaluation. BP variability is a new point to be considered in the future. Proteinuria but also other specific risk factors (Phosphate, anemia, inflammation,..) should be integrated in the management of hypertension in CKD

There are no comments yet on this publication. Be the first to share your thoughts.